About Sientra
Sientra is a publicly listed company based in Santa Barbara (United States) founded in 2007. Products for plastic surgery and aesthetics are developed and marketed. Sientra has raised $150 million across 3 funding rounds from investors including Goldman Sachs, Blackstone and TIAA. The company has 304 employees. Sientra has completed 1 acquisition, including miraDry. Its chief executive, as recorded, is Ron Menezes. Its focus areas include Life Sciences, Women Health, Medical Devices and Therapy. Its competitors include AirXpanders, BioAesthetics and Novasys Medical; 3 of its 3 listed competitors have raised funding.
Company details
Sientra was founded in 2007 in Santa Barbara, United States, with a focus on the plastic surgery and aesthetics sector. Products such as breast implants, breast tissue expanders, body contouring systems, and facial implants are developed and marketed by the company. Operations center on this specialized market, and the firm went public in October 2014 to support its growth.
- Headquarters Santa Barbara, United States
- Employees 304
- Stage Public
- SectorsHealthcare
- Website sientra.com
- Social LinkedIn
- Annual Revenue$90.55 M (USD)12as on Dec 31, 2022
- Net Profit-$73.31 M (USD)-17as on Dec 31, 2022
- EBITDA-$69.05 M (USD)-49as on Dec 31, 2022
- Total Equity Funding$150M (USD)
in 3 rounds
- Latest Funding Round$60M (USD), Post-IPO
Mar 2020
- InvestorsGoldman Sachs
& 5 more
- Employee Count304
- Investments & Acquisitions
Funding Insights of Sientra
Sientra has successfully raised a total of $150M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $60 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150M
- Total Rounds 3
- Last Round Post-IPO — $60M
- First Round $85M
(Apr 2007)
- Investors Count 6
All 3 funding rounds of Sientra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $60M | Post-IPO | – | – | |
| Mar 2012 | $65M | Series C | – | – | |
| Apr 2007 | $85M | Series B | – | – |
6 investors in total: 6 institutional.
Investors in Sientra
Sientra has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Blackstone and TIAA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States | |
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Investment banking services are delivered across multiple financial sectors. | 1869 | goldmansachs.com | New York, United States | |
Provider of retirement planning, investment, and wealth management services | 1918 | tiaa.org | New York, United States |
Investor details for Sientra
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sientra
19 people are tracked at Sientra (5 in leadership, 14 in team); the tracked headcount is 304.
| Name | Role | Group |
|---|---|---|
Ron Menezes | CEO | Leadership |
Tejas Patel | Vice President - Technology And Engineering | Leadership |
Floyd Amuchie | Vice President Finance | Leadership |
Jeff Harris | Vice President Of Reconstruction & Corporate Contracts | Leadership |
Jean Simon | Executive Director, Regulatory And Clinical Affairs | Leadership |
Brad Tolson | Plastic Surgery Consultant | Team |
Michael Hoeland | Post Market Surveillance Analyst | Team |
Daniel Lázaro Villalobos | Research Development Project Lead | Team |
John Scott | Manager - Business Systems | Team |
Lee Duensing | Principal Quality Engineer | Team |
Thomas Lytle | Senior Accountant | Team |
Madeline Garrett | Accounts Payable Lead | Team |
Neri Turcios | Sr. Accounts Receivable Specialist | Team |
Nicole Stevens | Accounts Receivable Specialist | Team |
Casey Yamada | Accountant | Team |
Daniel Alldred | Principal Quality Engineer | Team |
Bradley Grubb | Senior Manager Manufacturing Engineering | Team |
Alicia Lomeli | Clinical Research Associate | Team |
Amanda Maupin | Executive Plastic Surgery Consultant | Team |
Complete people profiles for Sientra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sientra
Sientra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include miraDry.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Underarm sweat and odor glands are eliminated noninvasively. | miradry.com | Newport Beach, United States | 2010 | Jun 2017 | •••• |
Complete acquisition details for Sientra
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sientra
5 dated milestones of Sientra across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Sientra is founded.
- Funding First funding round of $85.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires miraDry.
- Funding Latest funding round, Post-IPO, of $60.0M.
Competitors of Sientra
Sientra has 3 listed competitors in our database, 3 of them funded. They include AirXpanders, BioAesthetics and Novasys Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| airxpanders.com | 2006 | Mountain View, United States | $36.15M | 66 | Tissue expansion technology for breast reconstruction surgery is developed. | |
| bio-aesthetics.com | 2015 | New Orleans, United States | $7.4M | Tissue-engineered nipple-areolar complexes are developed for post-mastectomy use. | ||
| novasysmedical.com | 1999 | Newark, United States | $121.08M | Therapeutics for female pelvic disorders, including SUI treatments, were developed. |
Detailed competitors of Sientra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sientra
The website of Sientra (sientra.com) receives about 5.1K visits a month.
- Monthly visits5.1K
▼ 34.5% vs previous month
Websites whose visitors overlap most with Sientra. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| allergan.com | 100% | 7.2K | #2,945,554 | View details | |
dranmolchugh.com | dranmolchugh.com | 96% | #705,223 | – | |
| butterflynetwork.com | 93% | 155.6K | #163,726 | View details | |
| mentorwwllc.com | 91% | View details | |||
drrajatgupta.com | drrajatgupta.com | 89% | #1,912,342 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for Sientra
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Sientra (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sientra
Complete news archive for Sientra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sientra
Sientra was founded in 2007.
Sientra is headquartered in Santa Barbara, United States. It is registered at Santa Barbara, California, United States.
Ron Menezes is the CEO of Sientra, as recorded in our data.
Sientra is a funded company, having raised a total of $150M across 3 funding rounds to date. The company's 1st funding round was a Series B of $85M, raised on Apr 2007.
Sientra has 304 employees.
Annual revenue of Sientra is $90.55M as on Dec 31, 2022.
Sientra was founded in 2007 in Santa Barbara, United States, with a focus on the plastic surgery and aesthetics sector. Products such as breast implants, breast tissue expanders, body contouring systems, and facial implants are developed and marketed by the company. Operations center on this specialized market, and the firm went public in October 2014 to support its growth.
Sientra's top competitors include BioAesthetics, AirXpanders and Novasys Medical.
Sientra has made 1 acquisition, including miraDry.
Sientra has 6 investors. Key investors include Goldman Sachs, Blackstone, TIAA, Orbimed, and Abingworth.